Dr. Monica Yabal

Monica Yabal graduated from the University of Eastern Finland (Kuopio, Finland) with a Masters degree in Biotechnology. She then moved to the University of Helsinki (Helsinki, Finland) to pursue a PhD from the Faculty of Biosciences, under the supervision of Prof. Marja Makarow, where she studied the mechanism underlying the membrane insertion of C-Tail anchored proteins in the yeast model Saccharomyces Cerevisiae. 

After her PhD she then moved to Australia for a Post-Doc at the Walter and Eliza Hall Institute of Biomedical Research (WEHI) (Melbourne, Australia), under the supervision of Prof. David Huang, where she began to work in the field of cell death regulation (apoptosis) and specifically worked on the characterization of determinants regulating the induction of cell death by Bcl-2 protein family members. She then moved to the Technical University of Munich, at the School of Medicine, Klinikum rechts der Isar, to the Research group of Prof. Dr. Phillip Jost as a senior scientist. Here she worked on Role of inflammatory cell death (necroptosis) in tumorigenesis and discovered the key role for XIAP in controlling RIPK3 activation and inflammasome activation in myeloid cells.

As a research group leader at the Institute of Molecular Immunology, at the School of medicine, her work now focuses on the understanding the impact of inflammatory cell death on mucosal immune integrity.